Latest On Sino Biopharmaceutical Limited (SBHMY):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-10-04 05:59 EST | Dividend | A dividend of $0.05 has been announced on Sep 14, 2023. It will be paid Nov 13, 2023 with an ex-dividend date of Oct 4, 2023. | Neutral |  |
| 2023-06-20 06:00 EST | Dividend | A dividend of $0.15 has been announced on Jun 7, 2023. It will be paid Jul 31, 2023 with an ex-dividend date of Jun 20, 2023. | Neutral | |
| 2023-03-07 13:01 EST | News | F-star Therapeutics surges on report sale to Sino Biopharma close to CFIUS approval | N/A | |
| 2023-03-07 13:01 EST | News | F-star Therapeutics surges as buyer Sino Biopharma gains CFIUS approval | N/A | |
| 2023-02-23 22:33 EST | News | F-star Therapeutics jumps as it extends walk date with buyer to `finalize' CFIUS agreement | N/A | |
| 2023-02-08 15:43 EST | News | F-star Therapeutics gains as buyer Sino Biopharma cancels Shanghai listing | N/A | |
| 2022-12-30 17:08 EST | News | F-star Therapeutics rebounds as merger deadline extends again | N/A | |
| 2022-12-29 11:27 EST | News | F-star sinks ~37% as CFIUS objects Sino Biopharma deal | N/A | |
| 2022-12-19 11:03 EST | News | F-star Therapeutics gains after deal deadline extended again | N/A | |
| 2022-11-21 18:54 EST | News | F-star Therapeutics gains after extending sale end date to Sino-Biopharma to Dec. 19 | N/A | |
| 2022-09-06 05:59 EST | Dividend | A dividend of $0.15 has been announced on Aug 24, 2022. It will be paid Oct 13, 2022 with an ex-dividend date of Sep 6, 2022. | Neutral | |
| 2022-06-23 23:53 EST | News | F-star Therapeutics stock soars 71% as Sino Biopharma set to acquire it for $161M | N/A | |
| 2022-06-15 05:58 EST | Dividend | A dividend of $0.1 has been announced on May 18, 2022. It will be paid Jul 27, 2022 with an ex-dividend date of Jun 15, 2022. | Neutral | |
| 2021-09-10 05:59 EST | Dividend | A dividend of $0.05 has been announced on Sep 1, 2021. It will be paid Oct 19, 2021 with an ex-dividend date of Sep 10, 2021. | Neutral | |
| 2021-06-17 06:03 EST | Dividend | A dividend of $0.05 has been announced on Nov 30, -0001. It will be paid Jul 27, 2021 with an ex-dividend date of Jun 17, 2021. | Neutral | |
| 2020-12-11 05:00 EST | Dividend | A dividend of $0.05 has been announced on Nov 30, -0001. It will be paid Jan 15, 2021 with an ex-dividend date of Dec 11, 2020. | Neutral | |
| 2020-12-01 13:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 22:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 01:47 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 18:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 15:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-25 10:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 07:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-11 05:58 EST | Dividend | A dividend of $0.05 has been announced on Aug 31, 2020. It will be paid Oct 15, 2020 with an ex-dividend date of Sep 11, 2020. | Neutral | |
| 2020-08-29 10:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 11:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 14:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 10:24 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 18:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 06:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 22:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 14:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 19:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-20 02:12 EST | Stock Split | A stock split has occured on Jul 20, 2020 with a split factor of 1:1. | Neutral | |
| 2020-07-09 10:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 18:37 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 02:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 14:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 06:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 08:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-11 05:59 EST | Dividend | A dividend of $0.05 has been announced on May 11, 2020. It will be paid Jul 21, 2020 with an ex-dividend date of Jun 11, 2020. | Neutral | |
| 2020-06-07 03:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 07:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 02:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 07:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 18:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-20 06:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-09 02:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 22:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-25 22:18 EST | Financials | Company financials have been released. | Neutral | |
About Sino Biopharmaceutical Limited (SBHMY):
Sino Biopharmaceutical Limited, together with its subsidiaries, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. The company operates in three segments: Chinese Medicines, Investment, and Others. Its principal products include hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; oncology medicines comprising Saiweijian injections, Yinishu tablets, Shoufu tablets, Anxian capsules, and Qianping injections; cardio-cerebral medicines, including Yilunping tablets, Tuotuo tablets, and Kaina tablets; and orthopedic medicines, such as Gaisanchun capsules and Yigu injections. The company's principal products also comprise digestive system medicines that consist of Aisuping injections, Getai tablets, and Deyou granules; anti-infectious medicines that include Tiance injections, Tianjie injections, and Tianli injections; respiratory system medicines, such as Tianqingsule inhalation powder; and others comprising Debaian cataplasms. In addition, it engages in property holding activities; the retail and distribution of pharmaceutical products; optometry for optical glasses and sale of ophthalmic products; the provision of medical management consultancy services; and outpatient and surgical procedure. Further, the company manufactures, sells, and distributes health food; and develops medical technology. Sino Biopharmaceutical Limited was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.
General
- Name Sino Biopharmaceutical Limited
- Symbol SBHMY
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 24,328
- Last Split Factor1:1
- Last Split Date2020-08-14
- Fiscal Year EndDecember
- Web URLhttp://www.sinobiopharm.com
View More
Valuation
- Trailing PE 35.23
- Forward PE 46.51
- Price/Sales (Trailing 12 Mt.) 5.35
- Price/Book (Most Recent Quarter) 4.15
- Enterprise Value Revenue 0.81
- Enterprise Value EBITDA 3.38
View More
Financials
- Most Recent Quarter 2020-09-30
- Profit Margin 10%
- Return on Assets 4%
- Return on Equity 10%
- Earnings Per Share $0.66
- Revenue Per Share $0
- Gross Profit 19.31 billion
- Quarterly Earnings Growth -19.4%
View More
Highlights
- Market Capitalization 21.76 billion
- PEG Ratio 11.91
- Book Value Per Share $5.00
View More
Share Statistics
- Shares Outstanding 943.08 million
- Shares Float 444.76 million
- % Held by Insiders <1%
View More
Technicals
- Beta 0.56
- 52 Week High $39.55
- 52 Week Low $17.09
- 50 Day Moving Average 20.7
- 200 Day Moving Average 20.01
View More
Dividends
- Forward Annual Dividend Rate $0.21
- Forward Annual Dividend Yield 0.89%
- Payout Ratio 163%
- Dividend Date 2021-01-15
- ExDividend Date 2020-12-11
- Dividend Per Share $0.01
- Dividend Yield 0%
View More
Sino Biopharmaceutical Limited (SBHMY) Dividend Calendar:
SBHMY's last dividend payment was made to shareholders on January 15, 2021.
Sino Biopharmaceutical Limited pays out 163% of its earnings out as a dividend.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Sino Biopharmaceutical Limited (SBHMY) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-09-30 | $N/A | $0.10 | ||
| 2020-06-30 | 2020-09-30 | $N/A | $0.01 | ||
| 2020-03-31 | 2020-06-30 | $N/A | $0.00 | ||
| 2019-12-31 | 2020-03-31 | $N/A | $0.01 | ||
| 2019-09-30 | 2019-12-31 | $6.79 billion | $0.00 | ||
| 2019-06-30 | 2019-09-30 | $6.32 billion | $0.01 | ||
| 2019-03-31 | 2019-06-30 | $6.21 billion | $0.00 | ||
| 2018-12-31 | 2019-03-31 | $5.16 billion | $0.01 | ||
| 2018-09-30 | 2018-12-31 | $6 billion | $0.05 | ||
| 2018-06-30 | 2018-09-30 | $5.07 billion | $0.01 | ||
| 2018-03-31 | 2018-06-30 | $4.65 billion | $0.00 | ||
| 2017-12-31 | 2018-03-31 | $3.37 billion | $0.01 | ||
| 2017-09-30 | 2017-12-31 | $3.96 billion | $0.00 | ||
| 2017-06-30 | 2017-09-30 | $277.26 million | $0.01 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $3.86 billion | $0.00 | $0.00 | |
| 2016-12-31 | 2017-03-31 | $3.5 billion | $0.01 | $0.00 | |
| 2016-09-30 | 2016-12-31 | $0.00 | $0.00 | ||
| 2016-06-30 | 2016-09-30 | $0.00 | $0.00 | ||
| 2016-03-31 | 2016-06-30 | $0.00 | $0.00 | ||
| 2015-12-31 | 2016-03-31 | $0.00 | $0.00 | ||
| 2015-09-30 | 2015-12-31 | $0.00 | $0.00 | ||
| 2015-06-30 | 2015-09-30 | $0.00 | $0.00 | ||
| 2015-03-31 | 2015-06-30 | $0.00 | $0.00 | ||
| 2014-12-31 | 2015-03-31 | $0.00 | $0.00 | ||
| 2014-09-30 | 2014-12-31 | $0.00 | $0.00 | ||
| 2014-06-30 | 2014-09-30 | $0.00 | $0.00 | ||
| 2014-03-31 | 2014-06-30 | $0.00 | $0.00 | ||
| 2013-12-31 | 2014-03-31 | $0.00 | $0.00 | ||
| 2013-09-30 | 2013-12-31 | $0.00 | $0.00 | ||
| 2013-06-30 | 2013-09-30 | $0.00 | $0.00 | ||
| 2013-03-31 | 2013-06-30 | $0.00 | $0.00 | ||
| 2012-12-31 | 2013-03-31 | $0.00 | $0.00 | ||
| 2012-09-30 | 2012-12-31 | $0.00 | $0.00 | ||
| 2012-06-30 | 2012-09-30 | $0.00 | $0.00 | ||
| 2012-03-31 | 2012-06-30 | $0.00 | $0.00 | ||
| 2011-12-31 | 2012-03-31 | $0.00 | $0.00 | ||
| 2011-09-30 | 2011-12-31 | $0.00 | $0.00 | ||
| 2011-06-30 | 2011-09-30 | $0.00 | $0.00 | ||
| 2011-03-31 | 2011-06-30 | $0.00 | $0.00 | ||
| 2010-12-31 | 2011-03-31 | $0.00 | $0.00 | ||
| 2010-09-30 | 2010-12-31 | $0.00 | $0.00 |
Sino Biopharmaceutical Limited (SBHMY) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | N/A | N/A | N/A | 1.85 billion |
| Selling General Administrative | N/A | N/A | N/A | N/A | 3.34 billion |
| Gross Profit | N/A | N/A | N/A | N/A | 5.47 billion |
| Ebit | N/A | N/A | N/A | N/A | 1.7 billion |
| Operating Income | N/A | N/A | N/A | N/A | 1.7 billion |
| Income Tax Expense | 239.8 million | 325.64 million | 212.25 million | 57.19 million | 382.61 million |
| Total Revenue | N/A | N/A | N/A | N/A | 6.79 billion |
| Cost of Revenue | N/A | N/A | N/A | N/A | 1.32 billion |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | 149.3 million |
| Net Income From Continuing Operations | N/A | N/A | N/A | N/A | 1.47 billion |
| Net Income Applicable to Common Shares | 637.42 million | 351.06 million | 862.02 million | 451.28 million | 811.17 million |
Balance Sheet:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | N/A | N/A | 14.64 billion |
| Total Stockholder Equity | N/A | N/A | N/A | N/A | 30.58 billion |
| Other Current Liabilities | 7 billion | N/A | N/A | N/A | 6.92 billion |
| Total Assets | N/A | N/A | N/A | N/A | 53.77 billion |
| Common Stock | 416.14 million | 278.3 million | 278.32 million | 278.45 million | 278.45 million |
| Other Current Assets | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A |
| Other Liabilities | 1.86 billion | 1.89 billion | 1.87 billion | 1.97 billion | 2 billion |
| Other Assets | 1.53 billion | 1.59 billion | 1.66 billion | 2.28 billion | 2.4 billion |
| Cash | N/A | N/A | N/A | N/A | 6.14 billion |
| Total Current Liabilities | 9.94 billion | N/A | N/A | N/A | 10.09 billion |
| Other Stockholder Equity | 31.67 billion | 31.65 billion | 31.84 billion | 31.25 billion | 30.74 billion |
| Property, Plant & Equipment | 8.66 billion | 8.57 billion | 8.34 billion | 8.21 billion | 6.53 billion |
| Total Current Assets | 30.4 billion | N/A | N/A | N/A | 21.86 billion |
| Long Term Investments | N/A | N/A | N/A | N/A | 1.21 billion |
| Net Tangible Assets | 10.47 billion | 10.18 billion | 10.3 billion | 10.23 billion | 8.8 billion |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | 2.48 billion |
| Inventory | 1.76 billion | N/A | N/A | N/A | 1.59 billion |
| Accounts Payable | 2.36 billion | N/A | N/A | N/A | 2.37 billion |
Sino Biopharmaceutical Limited (SBHMY) Chart:
Sino Biopharmaceutical Limited (SBHMY) News:
Below you will find a list of latest news for Sino Biopharmaceutical Limited (SBHMY) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Sino Biopharmaceutical Limited (SBHMY) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Sino Biopharmaceutical Limited (SBHMY) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-01-24 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1604982/000101915520000020/0001019155-20-000020-index.htm |
| 2014-04-08 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1604982/000119380514000751/0001193805-14-000751-index.htm |
| 2016-05-25 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1604982/000119380516003321/0001193805-16-003321-index.htm |
| 2016-09-13 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1604982/000119380516003943/0001193805-16-003943-index.htm |
| 2017-09-29 | F-6 POS | Post-effective amendments for immediately effective filing | https://www.sec.gov/Archives/edgar/data/1604982/000119380517002605/0001193805-17-002605-index.htm |
| 2019-11-22 | F-6EF | Registration of American Depository Receipt shares, immediately effective | https://www.sec.gov/Archives/edgar/data/1604982/000119380519001656/0001193805-19-001656-index.htm |